McKesson
3
6M
3
0.02
1
- Areas of investment
Summary
McKesson is the famous Corporate Investor, which was founded in 1833. The fund was located in North America if to be more exact in United States. The leading representative office of defined Corporate Investor is situated in the San Francisco.
The usual things for fund are deals in the range of 5 - 10 millions dollars. The increased amount of exits for fund were in 2018. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2019.
Among the most successful fund investment fields, there are SaaS, Life Science. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Shyft, Xealth, Xealth. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the McKesson, startups are often financed by UPMC, Threshold, Froedtert Health. The meaningful sponsors for the fund in investment in the same round are UPMC, Threshold, Providence Ventures. In the next rounds fund is usually obtained by MemorialCare Innovation Fund, Cleveland Clinic, Atrium Health.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.02
- Investments by industry
- Health Care (3)
- Analytics (2)
- Therapeutics (1)
- Personal Health (1)
- Health Diagnostics (1) Show 2 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Group Appearance index
- 1.00
- Avg. company exit year
- 12
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| SHYFT | 29 Mar 2017 | Analytics, Health Care, Life Science, Pharmaceutical | Early Stage Venture | 7M | United States, Massachusetts |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.